Experts share the exact muscles you should work and exercises you should do to reduce (and prevent) common back pain and injuries.

Pelvic and lower back pain can occur at the same time for many reasons, ranging from arthritis to infections. If your pain is severe or lasts more than a few days, it’s important to see your doctor.

Lower back pain is a common and often debilitating health hardship, affecting nearly 600 million people globally. Here's how ...

Chronic back pain is the most common type of pain, affecting around 16 million American adults — and now a new study has revealed some discouraging findings about potential treatments. Only around one ...

If you’re trying to fix that nagging back pain—or more importantly prevent it—try the following strength exercises and lower back stretches, demonstrated by Hollis Tuttle, certified personal trainer ...

What kinds of shoes might be contributing to your back pain, and what kinds of shoes might help? Here’s what two podiatrists ...

Muscle aches are a common symptom of cold and influenza (flu) infections, and in some cases, these aches may affect the lower back. Persistent coughing may also lead to pain in the back. While people ...

This image of poor Jason Day was taken at the 2016 World Golf Championships. Long time ago, but when you think about Day's career, that's how long—if not longer—he has been dealing with back issues.

Add Yahoo as a preferred source to see more of our stories on Google. Waking up with lower back pain in the morning can put a damper on your day before it even begins. Whether it’s a dull ache or a ...

A few years ago, when several workers at a local plant reported lower back pain, one of the bosses requested I look at the situation to determine the problem and how to improve things. After studying ...

Findings of a real-world study confirm guidelines that recommend physical therapy as first-line treatment; it has a slight edge over cognitive-behavioral therapy.

Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced that its pivotal Phase 3 clinical trial evaluating rexlemestrocel-L ...